Bangalore (Karnataka) [India], June 20: Breast cancer remains one of the most prevalent cancers worldwide, affecting millions of women annually, and although less common, it can also occur in men. Dr Mahesh Bandemegal, a senior surgical oncologist with extensive experience in breast oncoplas
Breast cancer survivors have a much greater chance of having secondary cancers, including endometrial and ovarian cancer for women and prostate cancer for men, according to new research based on data from almost 600,000 patients in England.
Ahmedabad (Gujarat) [India], March 14: In a significant stride towards making advanced cancer treatment accessible to all, Zydus has launched Olaparib, a PARP inhibitor, under the brand name IBYRA in India. The drug will target specific genetic mutations prevalent in certain types of cancers
Boston [US]/ Noida (Uttar Pradesh) [India], February 15: Curadev is excited to introduce CRD3874, a first-in-class allosteric small molecule STING agonist, with distinct pharmacological properties that distinguish it from agents that bind to STING's cGAMP site. An intravenous formulation of
The OCTF's consensus guidelines were included in the journal Cancers as part of a scoping review that identified and compared the worldwide clinical practice guidelines for treating oral, oropharynx, and larynx cancer.
Australian scientists have identified a novel way for epithelial cells, which form layers in organs such as the skin and stomach, to adhere to one another and perceive growth signals at these attachments, allowing them to produce tissues of the proper size and shape.
Bangalore (Karnataka) [India]/Saratoga (California) [US]/Adelaide [Australia], December 8: Bugworks Research Inc., a clinical-stage biopharmaceutical company, is presenting the research findings on its novel, best-in-class, dual-acting adenosine antagonists BWC2094 and BWC2562 with the poten
Professor Nicholas Tonks' laboratory identified an antibody that can suppress an enzyme that may aid in the spread of some breast tumours. With more research, the antibody may be able to give a feasible therapeutic treatment for the same breast cancers.
New Delhi [India], October 31: Breast Cancer is the most common cancers in women in India. According to Breast Cancer India, one woman is diagnosed with the disease every four minutes and one woman dies of this disease in India every 8 minutes. India has a young population and hence, the num
An antibody developed in the lab of Cold Spring Harbour Laboratory Professor Nicholas Tonks can inhibit an enzyme that may aid in the spread of some breast tumours. With additional research, the antibody could provide a viable therapeutic treatment for the same breast tumours.
New Delhi [India], October 25: In an effort to raise awareness and provide valuable insights into uro-oncology, Dr Anil Kumar T, a distinguished expert in the field, is sharing his expertise and recommendations. With a wealth of experience in treating urological cancers, Dr Anil Kumar T aims
With an overall survival rate of more than 85% five years after diagnosis, the number of children cancer survivors in the United States is rising. However, survivors may still be more susceptible to a number of illnesses, such as second cancers.